Iowa 2023-2024 Regular Session

Iowa Senate Bill SF508

Introduced

3/2/23

Introduced

3/2/23

Caption

A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties.(Formerly SSB 1096.)

Impact

The implications of SF508 are significant in terms of public safety and law enforcement. It particularly targets the dangers posed by controlled substances when sold or distributed to minors. The bill introduces mandatory minimum sentences that remove the possibility for parole or work release in certain cases, thus locking offenders up for longer durations and geared towards discouraging these harmful activities. The law's broad applicability aims to combat the growing concern of drug-related incidents affecting the youth by holding accountable those who deliver harmful substances to minors.

Summary

Senate File 508 (SF508) aims to enhance regulations surrounding controlled substances, emphasizing severe penalties, particularly in relation to fentanyl. The bill broadens the definition of what constitutes a controlled substance and increases penalties for violations, especially those involving minors. Key provisions include that individuals convicted of manufacturing, delivering, or possessing large quantities of fentanyl will face more substantial sentences, including class B felonies with heavy fines and possible long-term confinement.

Contention

However, the bill has been met with both support and criticisms. Supporters argue that the stricter penalties are necessary to deter the increase in drug trafficking that disproportionately affects minors. Critics, on the other hand, express concerns about the potential for these harsher penalties to overwhelm the judicial system and disproportionately impact certain communities. They question whether the focus on punitive measures will effectively address the underlying issues related to substance abuse, calling for a more holistic approach that includes prevention and treatment alongside strict regulations.

Latest IA SF508 Activity

View All Events: IA 2023-2024 Regular Session SF508

Companion Bills

IA HF595

Similar To A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors; providing for immunity; and providing penalties. (Formerly HSB 104.) Effective date: 07/01/2023.

IA HSB104

Related A bill for an act relating to controlled substances including the manufacture, delivery, or possession of a controlled substance including fentanyl; the manufacture of a controlled substance in the presence of a minor; conspiracy to manufacture for delivery or delivery or intent or conspiracy to deliver a controlled substance to a minor; receipt, provision, and administration of opioid antagonists, including by secondary distributors, providing for immunity; and providing penalties.(See HF 595.)

IA SSB1096

Previously Filed As

IA HB4255

Crimes: controlled substances; crime of manufacturing, delivering, or possession of with intent to deliver certain controlled substances; modify penalties. Amends secs. 7401, 7410 & 7417 of 1978 PA 368 (MCL 333.7401 et seq.) & adds secs. 7410b & 7417a.

IA SB0460

Crimes: controlled substances; crime of manufacturing, creating, delivering, or possessing with intent certain schedule 1 and 2 controlled substances; modify penalties. Amends sec. 7401 of 1978 PA 368 (MCL 333.7401).

IA HF126

A bill for an act relating to penalties for the manufacture, delivery, or possession of certain amounts of controlled substances involving cocaine or cocaine base.

IA HB2828

Adds certain psychoactive substances to the list of Schedule I controlled substances and modifies the offenses of possession of a controlled substance and delivery of a controlled substance

IA SB0430

Crimes: controlled substances; crime of manufacturing, delivering, or possession of with intent to deliver heroin or fentanyl; modify to reflect changes in sentencing guidelines. Amends sec. 7401 of 1978 PA 368 (MCL 333.7401).

IA SB888

Manufacturing, selling, giving, distributing, or possessing with intent to manufacture, sell, give, or distribute a controlled substance or an imitation controlled substance prohibited; penalties.

IA HB1955

Manufacturing, selling, giving, distributing, or possessing with intent to manufacture, sell, give, or distribute a controlled substance or an imitation controlled substance prohibited; penalties.

IA SF305

A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(Formerly SSB 1080.)

IA HB1837

Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1 or 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.

IA SF328

Similar Bills

US SB331

HALT Fentanyl Act

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

US HB171

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.